During the past decade, Port Macquarie Base Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 9 clinical trials were completed, i.e. on average, 39.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Port Macquarie Base Hospital" #1 sponsor was "Merck Sharp & Dohme LLC" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Australasian Gastro-Intestinal Trials Group" with 2 trials sponsored, "Celgene" with 2 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Port Macquarie Base Hospital" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Academic and Community Cancer Research United" with 2 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 2 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Port Macquarie Base Hospital" are "Prostatic Neoplasms" (4 trials), "Breast Cancer" (3 trials), "Prostate Cancer" (3 trials), "Gastro-Oesophageal Cancer" (2 trials) and "Cancer of the Prostate" (1 trials). Many other conditions were trialed in "Port Macquarie Base Hospital" in a lesser frequency.

Most popular intervention types in "Port Macquarie Base Hospital" are "Drug" (31 trials), "Biological" (6 trials), "Other" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Docetaxel" (5 trials), "Enzalutamide" (5 trials), "Paclitaxel" (4 trials) and "Nivolumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Port Macquarie Base Hospital" are 21 trials for "All" genders, 9 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Port Macquarie Base Hospital". undefined are not yet recruiting, 6 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Port Macquarie Base Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Port Macquarie Base Hospital, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".